Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating fluorescein for sentinel lymph node biopsy in breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-04Clinical Trial Update: Lapatinib With Trastuzumab in Treating Patients With HER2-Negative/HER2 Mutant Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of lapatinib and trastuzumab for HER2-negative/HER2-mutant metastatic breast cancer has …
-
CLINICAL_TRIALS withdrawal · 2013-05-23Clinical Trial Update: Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer [Phase 2]
A Phase 2 trial of endocrine therapy plus OSI-906 with or without erlotinib for hormone-sensitive metastatic breast cancer has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2013-05-17Clinical Trial Update: Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer [Phase 1]
This clinical trial update notes the withdrawal of a Phase 1 study of ex vivo-expanded HER2-specific T cells with cyclophosphamide following…
-
CLINICAL_TRIALS withdrawal · 2013-05-17Clinical Trial Update: Evaluating an Internet-based Intervention for Insomnia in Breast Cancer Survivors [NA]
A clinical trial evaluating an internet-based intervention for insomnia in breast cancer survivors has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-05-08Clinical Trial Update: Drug Withdrawal in Women With Progressive Breast Cancer While on Aromatase Inhibitor Therapy
This clinical trial update reports on outcomes after withdrawing a drug in women with progressive breast cancer who are receiving aromatase …
-
CLINICAL_TRIALS withdrawal · 2013-05-07Clinical Trial Update: PTK and Letrozole in Post-menopausal Women With Advanced Breast Cancer [Phase 2]
Phase 2 trial of PTK in combination with Letrozole for postmenopausal women with advanced breast cancer has been terminated.
-
CLINICAL_TRIALS withdrawal · 2013-04-29Clinical Trial Update: Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer [Phase 1]
A Phase 1 trial of riluzole in women with-stage I to IIIA breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-04-10Clinical Trial Update: S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307
A SWOG clinical trial (S0307A/SWOG-S0307) evaluating long-term bone quality in women with breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-03-13Clinical Trial Update: A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer [Phase 2]
A Phase II randomized trial comparing lapatinib plus chemotherapy versus trastuzumab plus chemotherapy in HER2-positive and p95HER2-positive…
-
CLINICAL_TRIALS withdrawal · 2013-02-12Clinical Trial Update: Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer [Phase 2]
A Phase 2 trial investigating a treatment for aromatase inhibitor–associated arthralgia in breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-02-05Clinical Trial Update: Iyengar Yoga for Chemotherapy-induced Fatigue in Breast Cancer Patients [NA]
A clinical trial evaluating Iyengar Yoga for chemotherapy-induced fatigue in breast cancer patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-02-01Clinical Trial Update: Nurse-Provided Care or Standard Care in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer [NA]
A clinical trial comparing nurse-provided care to standard care for Stage I-III breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-01-24Clinical Trial Update: S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission [Phase 2]
The SWOG S0348 Vaccine Therapy trial for stage IIIB or stage IV breast cancer in remission was withdrawn from Phase 2.
-
CLINICAL_TRIALS withdrawal · 2013-01-11Clinical Trial Update: Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45
The NSABP-B-45 trial studying biomarkers of fatigue in women with residual invasive breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-01-03Clinical Trial Update: S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer [Phase 2]
This Phase 2 trial (S0511) evaluating goserelin in combination with anastrozole for men with recurrent or metastatic breast cancer has been …
-
CLINICAL_TRIALS withdrawal · 2012-12-17Clinical Trial Update: To Evaluate the Characteristics of a Breast Cancer [EARLY_Phase 1]
This clinical trial update notes that the EARLY Phase 1 study evaluating the characteristics of breast cancer (NCT01055678) has been withdra…
-
CLINICAL_TRIALS withdrawal · 2012-11-29Clinical Trial Update: Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS [Phase 3]
A Phase 3 trial evaluating risedronate to improve bone mineral density in postmenopausal women with ductal carcinoma in situ has been withdr…
-
CLINICAL_TRIALS withdrawal · 2012-11-14Clinical Trial Update: Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRI
Memorial Sloan Kettering Cancer Center's clinical trial evaluating changes in background parenchymal enhancement and fibroglandular tissue o…
-
CLINICAL_TRIALS withdrawal · 2012-10-29Clinical Trial Update: Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancer [Phase 2]
A Phase 2 trial evaluating PF-04691502 in combination with exemestane versus exemestane alone for advanced breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-10-24Clinical Trial Update: A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of chemotherapy, trastuzumab, and RAD001 (everolimus) for HER2-positive breast cancer ha…
-
CLINICAL_TRIALS withdrawal · 2012-09-25Clinical Trial Update: Management of Metastatic Breast Cancer in Frail Patients [Phase 2]
A Phase 2 clinical trial evaluating management of metastatic breast cancer in frail patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-31Clinical Trial Update: Molecular Triaging of Newly Diagnosed Breast Cancer [NA]
The clinical trial NCT01159236, titled 'Molecular Triaging of Newly Diagnosed Breast Cancer,' has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-31Clinical Trial Update: Low Level Laser Therapy for Hair Preservation With Chemotherapy for Breast Cancer [NA]
This clinical trial update indicates that a Northwestern University study evaluating low-level laser therapy to preserve hair during chemoth…
-
CLINICAL_TRIALS withdrawal · 2012-07-30Clinical Trial Update: CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer [Phase 2]
The CETRA Phase 2 trial of neoadjuvant Caelyx (pegylated liposomal doxorubicin) and trastuzumab in HER2-positive breast cancer has been with…